Evidence map›Paper›PMID 30065265›Full record

ArticleScientific reports2018

S100P enhances the motility and invasion of human trophoblast cell lines.

Maral E A Tabrizi, Tara L Lancaster, Thamir M Ismail, Athina Georgiadou, Ankana Ganguly, Jayna J Mistry, Keqing Wang, Philip S Rudland, Shakil Ahmad, Stephane R Gross

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Maral E A TabriziSchool of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.
Tara L LancasterSchool of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.
Thamir M IsmailInstitute of Integrative Biology, University of Liverpool, Biosciences Building, Crown Street, Liverpool, L69 7ZB, UK.
Athina GeorgiadouAston Medical Research Institute, Aston Medical School, Aston University, Birmingham, B4 7ET, UK.
Ankana GangulyInstitute of Metabolism and Systems Research, the University of Birmingham, Birmingham, B15 2TT, UK.
Jayna J MistrySchool of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.
Keqing WangAston Medical Research Institute, Aston Medical School, Aston University, Birmingham, B4 7ET, UK.
Philip S RudlandInstitute of Integrative Biology, University of Liverpool, Biosciences Building, Crown Street, Liverpool, L69 7ZB, UK.
Shakil AhmadAston Medical Research Institute, Aston Medical School, Aston University, Birmingham, B4 7ET, UK.ORCID 0000-0002-9294-0475
Stephane R GrossSchool of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK. S.R.Gross@aston.ac.uk.
Aston University · GBUniversity of Liverpool · GBUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

S100P has been shown to be a marker for carcinogenesis where its expression in solid tumours correlates with metastasis and a poor patient prognosis. This protein's role in any physiological process is, however, unknown. Here we first show that S100P is expressed both in trophoblasts in vivo as well as in some corresponding cell lines in culture. We demonstrate that S100P is predominantly expressed during the early stage of placental formation with its highest expression levels occurring during the first trimester of gestation, particularly in the invading columns and anchoring villi. Using gain or loss of function studies through overexpression or knockdown of S100P expression respectively, our work shows that S100P stimulates both cell motility and cellular invasion in different trophoblastic and first trimester EVT cell lines. Interestingly, cell invasion was seen to be more dramatically affected than cell migration. Our results suggest that S100P may be acting as an important regulator of trophoblast invasion during placentation. This finding sheds new light on a hitherto uncharacterized molecular mechanism which may, in turn, lead to the identification of novel targets that may explain why significant numbers of confirmed human pregnancies suffer complications through poor placental implantation.

Indexed as

Calcium-Binding ProteinsCell LineCell MovementFemaleHumansNeoplasm InvasivenessNeoplasm ProteinsPlacentaPlacentationPregnancyPregnancy Trimester, FirstTrophoblastsCalcium-Binding ProteinsNeoplasm ProteinsS100P protein, human

Identifiers

PMID30065265
PMCPMC6068119
OpenAlexW2884607207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.